120+ year industry veteran expands presence in Midwestern US, broadens cleanroom, histology, and microscopy portfolio. SWEDESBORO, NEW JERSEY – North America’s largest pure-play distributor of scientific products, Thomas Scientific, has officially acquired Minneapolis-based laboratory equipment and cleanroom supply provider North Central Instruments, Inc. (NCI). Finalized August 1st, the deal immediately extends Thomas Scientific’s national footprint while [...]

License allows Transomic Technologies to develop and commercialize products using CRISPR/Cas9. Dublin, Ireland and Huntsville, AL, USA,  August 3, 2023:  ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Transomic Technologies (‘Transomic,’). This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio. Dr. Emmanuelle Charpentier, [...]

Hong Kong -- Today, the Future Technology: AI Empowering Bioprocessing Development summit hosted by Great Bay Bio (hereinafter referred to as “GBB”) was successfully held at the Suzhou International Expo Center, where industry players gathered to celebrate the feast of technological innovation. At the summit, Great Bay Bio announced the official launch of its self-developed AI-enabled, [...]

PacBio will Combine Apton's Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemistry to Develop a High-Throughput Sequencer Designed to Deliver Billions of Reads per Flow Cell MENLO PARK, Calif. -- PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced that it has entered into an agreement to acquire Apton Biosystems, Inc (Apton), [...]

The Onso Platform Delivers Extraordinary Accuracy Which Creates New Possibilities for Research and Translational Sequencing Applications MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read sequencing instruments will commence today. As previously announced, the Onso system is designed to provide extraordinary accuracy through its novel sequencing [...]

Complete collaborative environment with intuitive interface addresses common analysis challenges to help accelerate transition from scientific discovery to data-driven precision medicine MOUNTAIN VIEW, Calif., and LUGANO, Switzerland — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced a collaboration with BigOmics Analytics, a Swiss biomedical data [...]

ST. NEOTS, UK -- ePrep is happy to announce that its quality management system has been certified to the international ISO 9001 standard, demonstrating the company’s dedication to providing the best possible service and products to its clients. The evaluation was carried out by Global-Mark Certifications, which put the business under the microscope to assessing not [...]

LAS VEGAS -- Altogen Biosystems announced the launch of a new lungs-targeted in vivo transfection reagent. The reagent is crafted to transport small molecules, DNA, RNA, and proteins to the lungs tissue, aiming to treat lung diseases, including cystic fibrosis and lung cancer. The transfection reagent is a non-viral complex comprising nanoparticle-sized cationic liposomes that play [...]

On August 1, 2023, Anton Paar acquired the German company Brabender, which will be integrated into the Anton Paar Group as Anton Paar TorqueTec GmbH. The effective, retroactive date of the acquisition is January 1, 2023. The company, based in Duisburg, Germany, offers measurement and process engineering solutions for the testing of various raw materials and [...]

BEIJING -- Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all around RMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX Capital; Pre-A+ is exclusively invested by Alibaba Health. The fund will mainly go towards the R&D of [...]